127 related articles for article (PubMed ID: 498164)
21. Multimodal therapy in the treatment of breast cancer.
Levitt SH; Khan FM; Boen JR; Potish RA; Bowers BJ
Am J Clin Oncol; 1983 Aug; 6(4):387-91. PubMed ID: 6688149
[No Abstract] [Full Text] [Related]
22. A study over a 5-year period of adjuvant chemotherapy after mastectomy for breast cancer.
Fennelly JJ; Cantwell B; Jones M
Ir Med J; 1981 Feb; 74(2):46-8. PubMed ID: 7228618
[No Abstract] [Full Text] [Related]
23. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
Sulkes A; Brufman G; Rizel S; Weshler Z; Biran S; Fuks Z
Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):17-21. PubMed ID: 6687724
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment].
Waibel PJ; Jungi WF; Senn HJ
Dtsch Med Wochenschr; 1983 Dec; 108(48):1827-32. PubMed ID: 6641535
[TBL] [Abstract][Full Text] [Related]
25. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
27. Adjuvant chemotherapy of breast cancer.
Cooper RG; Holland JF; Glidewell O
Cancer; 1979 Sep; 44(3):793-8. PubMed ID: 476594
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
Senn HJ; Jungi WF; Amgwerd R; Sprenger F; Hochuli E; Engelhart G; Heinz C; Wick A; Enderlin F; Simeon B; Lanz R; Bigler R
Haematol Blood Transfus; 1978; 22():47-60. PubMed ID: 374199
[No Abstract] [Full Text] [Related]
29. A five-drug combination in the treatment of metastatic breast cancer.
Falkson G; Falkson HC
Cancer Clin Trials; 1981; 4(1):81-5. PubMed ID: 7214665
[TBL] [Abstract][Full Text] [Related]
30. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
Smalley RV; Lefante J; Bartolucci A; Carpenter J; Vogel C; Krauss S
Breast Cancer Res Treat; 1983; 3(2):209-20. PubMed ID: 6688538
[TBL] [Abstract][Full Text] [Related]
31. [Bone marrow necrosis in a patient with metastatic breast cancer in chemotherapy with chlorambucil, methotrexate and prednisone].
Voigtmann R
Onkologie; 1989 Feb; 12(1):36-8, 40. PubMed ID: 2541386
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy in disseminated carcinoma of the breast.
Kaufman S; Goldstein M
Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
[No Abstract] [Full Text] [Related]
33. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
34. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Carter SK
Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
[No Abstract] [Full Text] [Related]
36. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
37. Management of non-resectable (stage III) breast cancer.
Sponzo RW; Cunningham TJ; Caradonna RR; Antemann R
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1475-8. PubMed ID: 536258
[No Abstract] [Full Text] [Related]
38. Combined chemo- and hormonal therapy in advanced breast cancer.
Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
[No Abstract] [Full Text] [Related]
39. Combination chemotherapy in disseminated carcinoma of the breast.
Stutz FH; Blom J; Tormey DC
Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
[No Abstract] [Full Text] [Related]
40. 5-drug adjuvant chemotherapy for breast cancer.
Carey RW; Sohier WD; Kaufman S; Weitzman SA; Kelley RM; Lew RA; Halpern E
Cancer; 1979 Jul; 44(1):35-41. PubMed ID: 455262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
